William Amsbaugh
Direttore Tecnico/Scientifico/R&S presso Cure Ventures Management LP
Posizioni attive di William Amsbaugh
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Cure Ventures Management LP
 Cure Ventures Management LP Investment ManagersFinance Cure Ventures Management LP (Cure Ventures) is a venture capital firm founded in 2021 by David R Fallace, Richard J Lim and Lou A Tartaglia. The firm is headquartered in Boston, Massachusetts. | Direttore Tecnico/Scientifico/R&S | 01/07/2021 | - |
| Investitore di Private Equity | 01/07/2021 | - |
Storia della carriera di William Amsbaugh
Precedenti posizioni note di William Amsbaugh
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Cogitas Holdings, Inc.
 Cogitas Holdings, Inc. Information Technology ServicesTechnology Services Cogitas Holdings, Inc. provides healthcare IT services. The American company was founded by Stephen Ellis. | Direttore Tecnico/Scientifico/R&S | 01/01/2014 | 30/06/2021 |
| CONSTELLATION PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 01/01/2012 | 01/07/2014 |
Formazione di William Amsbaugh
| Western New England University | Undergraduate Degree |
| Boston University | Graduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 6 |
Posizioni
| Chief Tech/Sci/R&D Officer | 2 |
| Private Equity Investor | 1 |
| Director/Board Member | 1 |
Settori
| Consumer Services | 3 |
| Finance | 2 |
| Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 3 |
|---|---|
Cure Ventures Management LP
Cure Ventures Management LP Investment ManagersFinance Cure Ventures Management LP (Cure Ventures) is a venture capital firm founded in 2021 by David R Fallace, Richard J Lim and Lou A Tartaglia. The firm is headquartered in Boston, Massachusetts. | Finance |
Constellation Pharmaceuticals, Inc.
 Constellation Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Constellation Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel therapeutics in the field of epigenetics. The firm utilizes epigenetics platform, which enables to validate targets and generate small molecules against these targets that selectively modulate gene expression in tumor and immune cells to drive anti-tumor activity. Its product include CPI-0610, CPI-1205, and CPI-0209. The company was founded by Danny Reinberg, David Allis, and Yang Shi on January 11, 2008 and is headquartered in Cambridge, MA. | Health Technology |
Cogitas Holdings, Inc.
Cogitas Holdings, Inc. Information Technology ServicesTechnology Services Cogitas Holdings, Inc. provides healthcare IT services. The American company was founded by Stephen Ellis. | Technology Services |
- Borsa valori
- Insiders
- William Amsbaugh
- Esperienza
